SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-19-004034
Filing Date
2019-06-03
Accepted
2019-06-03 19:14:54
Documents
2
Period of Report
2019-05-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-45170.html 3  
1 PRIMARY DOCUMENT marketforms-45170.xml 3 2323
2 POA DOCUMENT poa.htm EX-24 3953
  Complete submission text file 0001214659-19-004034.txt   7704
Mailing Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008
Business Address 5421 AVENIDA ENCINAS SUITE F San Diego CA 92008 858-480-2400
OBALON THERAPEUTICS INC (Issuer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O OBALON THERAPEUTICS INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD CA 92008
Business Address
MacDonald Robert J (Reporting) CIK: 0001778547 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37897 | Film No.: 19874908